In 2020, the Sars-Cov-2 pandemic is causing a huge and dramatic impact on healthcare systems worldwide. During this emergency, fragile patients suffering from other comorbidities, especially patients susceptible to or affected by cardiovascular disease, are the ones most exposed to the poorer outcomes. Therefore, it is still mandatory to continue to strictly adhere to the rules of cardiovascular prevention. This document aims to provide all doctors with simple and clear recommendations in order to spread useful messages to the widest number of subjects in order to continue the battle against cardiovascular diseases even in times of pandemic.

Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic : An Executive Document by the Board of the Italian Society of Cardiovascular Prevention / M. Volpe, A. Battistoni, P. Bellotti, S. Bellone, M. Bertolotti, A. Biffi, A. Consoli, A. Corsini, G. Desideri, C. Ferri, M.G. Modena, G. Nati, M. Pirro, S. Rubattu, G. Tocci, B. Trimarco, R. Volpe, S.V. de Kreutzenberg. - In: HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION. - ISSN 1120-9879. - (2020 Jul 30). [Epub ahead of print] [10.1007/s40292-020-00401-1]

Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic : An Executive Document by the Board of the Italian Society of Cardiovascular Prevention

A. Corsini
Writing – Original Draft Preparation
;
2020

Abstract

In 2020, the Sars-Cov-2 pandemic is causing a huge and dramatic impact on healthcare systems worldwide. During this emergency, fragile patients suffering from other comorbidities, especially patients susceptible to or affected by cardiovascular disease, are the ones most exposed to the poorer outcomes. Therefore, it is still mandatory to continue to strictly adhere to the rules of cardiovascular prevention. This document aims to provide all doctors with simple and clear recommendations in order to spread useful messages to the widest number of subjects in order to continue the battle against cardiovascular diseases even in times of pandemic.
Cardiovascular prevention; Cardiovascular risk; Covid-19; Sars-Cov-2
Settore BIO/14 - Farmacologia
30-lug-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
Volpe2020_Article_RecommendationsForCardiovascul.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 645.32 kB
Formato Adobe PDF
645.32 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/761222
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 12
social impact